| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/07/2007 | CN1923260A Medicine for treating coronary disease of stenocardia type and its preparation method |
| 03/07/2007 | CN1923249A Traditional Chinese medicine for treating vasculitis by using inbreathed drug smoke |
| 03/07/2007 | CN1923241A Medicine composition containing epimedium extract, uncaria extract, and gastrodine, and its preparation and use |
| 03/07/2007 | CN1923229A Pharmaceutical composition comprising notoginseng extract, Danshen extract and puerarin |
| 03/07/2007 | CN1923228A Pharmaceutical composition comprising notoginseng extract, Danshen extract and ligustrazine |
| 03/07/2007 | CN1923227A Traditional Chinese medicinal formulation for treating ischemic cardiovascular and cerebrovascular diseases and preparation method thereof |
| 03/07/2007 | CN1923221A Novel pharmaceutical composition containing American ginseng extract, hirudo extract AND carthamus tinctorius yellow colour |
| 03/07/2007 | CN1923220A Ginkgo damo powder injection and its preparing process |
| 03/07/2007 | CN1923211A Astragaloside injection and preparation thereof |
| 03/07/2007 | CN1923210A Diructose anhydride-containing composition and use thereof |
| 03/07/2007 | CN1923206A Application of ketanserin in preparing medicine for preventing cerebral apoplexy |
| 03/07/2007 | CN1923191A Use of flavanone kind composition in preparation of medicine for curing cardio vascular diseases |
| 03/07/2007 | CN1923185A Gastrodine tablets disintegrating in oral cavity and process for producing same |
| 03/07/2007 | CN1923182A Lacidipine tablets disintegrating in oral cavity and process for producing same |
| 03/07/2007 | CN1923181A Valsartan drops and its preparation method |
| 03/07/2007 | CN1923180A Meglumine cyclic adenosine for injecta and its preparing process |
| 03/07/2007 | CN1923176A Oil-in-water baicalin nano-milk oral liquid and its preparing process |
| 03/07/2007 | CN1923166A Carbediolo controlled release formulation |
| 03/07/2007 | CN1303103C Transmembrane NFAT inhibitory peptide |
| 03/07/2007 | CN1303082C 3-phenyl-3.7-diazobicyclo [3,3,1] nonane compound and its preparation method and medicine containing it |
| 03/07/2007 | CN1303074C Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 03/07/2007 | CN1303072C 7-oxo pyridopyrimidines |
| 03/07/2007 | CN1303067C Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 03/07/2007 | CN1303066C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 03/07/2007 | CN1302811C Externally-applicated chewing gum including chip-like center |
| 03/07/2007 | CN1302799C Oral Chinese medicinal composition for treating virus myocarditis |
| 03/07/2007 | CN1302775C Use of ligustilide for prevention and treatment of atherosclerosis |
| 03/07/2007 | CN1302774C Efferverscent tablets containing troxerutin and their preparation |
| 03/07/2007 | CN1302772C Orally disintegrated sodium ferulate tablet and its prepn process |
| 03/07/2007 | CN1302767C Apoplexy treating injection |
| 03/06/2007 | US7186870 Cyclization by reacting 4-(2-CHLORO-4-TRIFLUOROMETHYL-PHENYL)-4-CYANO-BUT-3-ENOIC ACID METHYL ESTER in the presence of a palladium catalyst and a base; chemical intermediates for preparing 10-AZA-TRICYCLO[6.3.1.02,7] drugs; bind nicotinic acetylcholine receptor, modulate cholinergic function |
| 03/06/2007 | US7186864 Trifluoromethyl-substituted nitrogen compounds; treating type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumors, and glaucoma |
| 03/06/2007 | US7186838 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 03/06/2007 | US7186826 Phosphorus-containing compounds and uses thereof |
| 03/06/2007 | US7186825 Polyamines for treatment of diseases such as cancer or treatment of tumors |
| 03/06/2007 | US7186753 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents |
| 03/06/2007 | US7186752 Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 03/06/2007 | US7186748 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 03/06/2007 | US7186745 Angiogenesis inhibitors |
| 03/06/2007 | US7186737 Inhibitors of p38 |
| 03/06/2007 | US7186734 Binding to antagonist or inverse antagonist as antiinflammatory agentsand immunological disorders |
| 03/06/2007 | US7186732 For therapy and prophylaxis of upper airway allergic response, nasal congestion, or allergic rhinitis, dementia, mild cognitive impairment (pre-dementia), cognitive dysfunction, schizophrenia, depression, manic disorders |
| 03/06/2007 | US7186720 Moderator of tumor necrosis factor; antiinflammatory agents; autoimmune diseases |
| 03/06/2007 | US7186718 For therapy of autoimmune, inflammatory, proliferative and hyperproliferative diseases and immunologically-mediated diseases including rejection of transplanted organs or tissues and Acquired Immunodeficiency Syndrome (AIDS |
| 03/06/2007 | US7186717 Pyrrolidine derivatives as Factor Xa inhibitors |
| 03/06/2007 | US7186710 PDE4/7 inhibitors useful in treatment of airway disorders, autoimmune system disorders, skin disorders, arthritis, nerve system disorders |
| 03/06/2007 | US7186708 Steroidal compounds |
| 03/06/2007 | US7186704 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis |
| 03/06/2007 | US7186407 Including claudication and critical limb ischemia, by administering fibroblast growth factor (FGF) in two doses, a single dose administered into each leg of the patient within one hour |
| 03/06/2007 | CA2389264C Partial or full a1 agonists - n6 heterocyclic 5'-thio substituted adenosine derivatives |
| 03/06/2007 | CA2384525C Thienylhydrazon with digitalis-like properties (positive inotropic effects) |
| 03/06/2007 | CA2191677C Cerebral function improving agents |
| 03/06/2007 | CA2189131C Use of pteridine derivatives as no-synthase inhibitors |
| 03/06/2007 | CA2168319C 4-mercaptobenzoylguanidine derivatives |
| 03/06/2007 | CA2163935C 17-(3-imino-2-alkypropenyl)-5.beta., 14.beta.-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same |
| 03/06/2007 | CA2129159C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 03/06/2007 | CA2128142C Pharmaceutical combination containing ras inhibitor and endothelin antagonist for the treatment of cardiovascular disorders |
| 03/01/2007 | WO2007024008A1 Preventive or therapeutic agent for side effect based on cytotoxicity of anticancer therapy containing apoptosis inhibition activity-enhancing protein fnk or nucleic acid encoding the same |
| 03/01/2007 | WO2007024004A1 Phenylpyridone derivative |
| 03/01/2007 | WO2007023882A1 Derivative having ppar agonistic activity |
| 03/01/2007 | WO2007023880A1 Chemokine production inhibitor |
| 03/01/2007 | WO2007023815A1 Therapeutic drug for heart disease and virus disease |
| 03/01/2007 | WO2007023775A1 Therapeutic agent for atrial fibrillation |
| 03/01/2007 | WO2007023774A1 Agent for amelioration of impaired ophthalmic arterial blood flow |
| 03/01/2007 | WO2007022991A1 Compositions and methods for improving functional vascular integrity, cellular survival and reducing apoptosis in ischemia or after ischemic episode in the brain |
| 03/01/2007 | WO2007022568A1 Reducing myocardial damage and the incidence of arrhythmia arising from loss, reduction or interruption in coronary blood flow |
| 03/01/2007 | WO2006138265A3 Heterocyclic aspartyl protease inhibitors, preparation and use thereof |
| 03/01/2007 | WO2006122186A3 1,4-diphenyl-3-hydroxyalkyl-2-azetidinone derivatives for treating hypercholestrolemia |
| 03/01/2007 | WO2006031922A3 Thyroid hormone analogs for promoting angiogenesis |
| 03/01/2007 | US20070049735 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070049639 Administering a combination of an omega-3 fatty acid and aspirin, to a patient suffering from inflammation, arthritis or cardiovascular diseases; reduced side effects; 13-hydroxy-DHA (13-hydroxy-DHA) |
| 03/01/2007 | US20070049620 Cyclic tertiary amine compound |
| 03/01/2007 | US20070049600 Pteridinones as kinase inhibitors |
| 03/01/2007 | US20070049594 Novel compounds and compositions as cathepsin inhibitors |
| 03/01/2007 | US20070049583 Benzoxazine and benzothiazine derivatives and their use in pharmaceutical agents |
| 03/01/2007 | US20070049566 Methods and Compositions for inhibition of angiogenesis |
| 03/01/2007 | US20070049535 Preventive/remedy for diabetic complications using oligopeptide |
| 03/01/2007 | US20070049531 GLP-1 agonist and cardiovascular complations |
| 03/01/2007 | US20070048772 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 03/01/2007 | US20070048319 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070048284 Cardiac arrhythmia treatment methods |
| 03/01/2007 | US20070048221 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070048220 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070048215 Chemical compound and assay |
| 03/01/2007 | US20070044795 Method and apparatus for dispensing inhalator medicament |
| 03/01/2007 | DE102005040841A1 Combination preparation, useful for the treatment of e.g. hypertonia, comprises thiazide diuretic, preferably hydrochlorothiazide and a loop diuretic, preferably torseamide, as active substances |
| 03/01/2007 | CA2661448A1 Reducing myocardial damage and the incidence of arrhythmia arising from loss, reduction or interruption in coronary blood flow |
| 03/01/2007 | CA2622904A1 Self-assembling nanoparticles for the treatment of vascular diseases |
| 03/01/2007 | CA2621164A1 Derivative having ppar agonistic activity |
| 03/01/2007 | CA2620024A1 Compositions and methods for improving functional vascular integrity, cellular survival and reducing apoptosis in ischemia or after ischemic episode in the brain |
| 03/01/2007 | CA2619770A1 Phenylpyridone derivative |
| 03/01/2007 | CA2617519A1 Agent for treating atrial fibrillation |
| 02/28/2007 | EP1757689A2 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
| 02/28/2007 | EP1757618A2 Angiogenesis-associated proteins, and nucleic acids encoding the same |
| 02/28/2007 | EP1757596A1 Tyrosine derivatives substituted by n-phenylacryloyl as agonists of hppar alpha and hppar gama |
| 02/28/2007 | EP1757594A1 Quinazoline derivative |
| 02/28/2007 | EP1757584A1 Heterocyclic substituted amides, their production and their use |
| 02/28/2007 | EP1757325A1 Use of botulinum toxin for treating myofascial pain |
| 02/28/2007 | EP1757324A2 Agent for preventing, improving or treating hypertension |
| 02/28/2007 | EP1757321A2 Methods and apparatus for relieving headaches, rhinitis and other common ailments |